卵清蛋白八聚体肽
卵清蛋白八聚体肽 性质
溶解度 | DMF:2mg/mL; DMSO:2mg/mL;乙醇:insol; PBS (pH 7.2):不溶 |
---|---|
形态 | 固体 |
颜色 | 白色至米白色 |
序列 | H-Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-OH |
卵清蛋白八聚体肽 用途与合成方法
TAP1-I- and C57BL/6 macrophages may process Crl-OVA and full-length OVA in different cellular compartments and that the protein context of the OVA Peptide(257-264) epitope influences the extent of TAP-independent processing for MHC class I presentation. OVA Peptide(257-264) epitope is presented with a differential dependence on the TAP transporter depending on the protein context of the OVA epitope: OVA Peptide(257-264) contained within the MBPCrl-OVA or Crl-OVA bacterial fusion proteins is presented with little dependence on the TAP transporter, while OVA Peptide(257-264) contained within full-length ovalbumin is largely dependent on the TAP transporter, regardless of whether recombinant OVA is expressed in bacteria or the native protein is coupled to polystyrene beads.
纯度(HPLC) ≥98.0%
醋酸根含量≤12.0%
水分含量≤8.0%
肽含量≥80.0%
内毒素≤50EU/mg
氨基酸组成分析≤±10%
卵清蛋白八聚体肽 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-11-08 | HY-P1489A | OVA Peptide (257-264) TFA | 1262751-08-5 | 1mg | 900 |
2024-11-08 | HY-P1489A | OVA Peptide (257-264) TFA | 1262751-08-5 | 5mg | 3600 |